V. Unnikrishnan Ramachandran

The Rise of GLP-1 Agonists: The Paradigm-shifting Frontier in Diabetic Kidney Disease, Cardio-renal Protection and Beyond

Fousiya Yoonus, E. K. Jayakumar, K. S. Sajeev Kumar, Krishna Suresh, V. Unnikrishnan Ramachandran, Nishita Mohan Philip, Dina Clerin Francis & Avin Alex · Asian Journal of Research in Nephrology · 2026

GLP 1 agonists have evolved into one of the most potent weapons in the arsenal to tackle diabetes and metabolic disease, while providing significant cardiorenal outcomes, as cemented by the FLOW trial. Their pleiotropic action extends into spheres of immune regulation, alleviatio...